Skip to content
  • Thursday, May 8, 2025
FrankTrades.com | Stock Market News, Stock Options Flow, Dark Pool, Product Reviews & more!

FrankTrades.com | Stock Market News, Stock Options Flow, Dark Pool, Product Reviews & more!

Frank is Frank

TradingView - Try it now!

  • Loading stock data...

  • Home
  • News
  • Blog
    • Rants
    • Stock Market Weekly Briefing
    • Motivate
    • Thoughts
  • Reviews
    • Books
    • Films
    • Recommendations
  • Film
  • Investing Tools
    • BlackBoxStocks
    • Tradingview
    • M1 Finance
    • Tastyworks
  • Referrals
  • Resources
    • Quizzes
    • Articles
    • Class Action Lawsuits
  • Subscribe
  • Home
  • 2023
  • May
  • 31
  • 📰 $NOVN TARGETS PDUFA DATE OF JAN. 5, 2024 FOR BERDAZIMER GEL CUTTING 50% OF EMPLOYEES
News

📰 $NOVN TARGETS PDUFA DATE OF JAN. 5, 2024 FOR BERDAZIMER GEL CUTTING 50% OF EMPLOYEES

May 31, 2023
Frank

$NOVN TARGETS PDUFA DATE OF JAN. 5, 2024 FOR BERDAZIMER GEL

CUTTING 50% OF EMPLOYEES

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on LinkedIn (Opens in new window) LinkedIn

Like this:

Like Loading...
Tags: Stock Market, Tweet

Post navigation

📰 $CRM 1Q REV. $8.25B, +11% Y/Y 1Q ADJ EPS $1.69 VS. 98C Y/Y 1Q ADJ. OPER MARGIN 27.6%, EST. 25.5% 1Q PROFESSIONAL SERVICES AND OTHER REV. $605M, EST. $613.3M STILL SEES FY REV. $34.5B TO $34.7B, EST. $34.63B SEES 2Q REV. $8.51B TO $8.53B, EST. $8.49B
📰 $AZN LYNPARZA COMBO OK’D BY FDA

Reviews

Film Reviews Letterboxd Reviews

Watched: Thelma, 2024 – ★★★★★

June 30, 2024
Frank
Books Goodreads Reviews

‘Joyful Recollections of Trauma’ by Paul Scheer

June 8, 2024
Frank
Film Reviews Films Reviews

Dumb Money (2023)

January 24, 2024
Frank
Reviews

One Second After by William R. Forstchen

April 15, 2023
Frank

August 12, 2020
1731 days ago.

    Trading involves substantial risk of loss and is not suitable for every investor.
    The information provided should not be considered as a recommendation or financial advice. Information provided in this poorly written blog shouldn’t be considered as a recommendation or financial advice, but only opinion. Few links may be affiliated.

    Visits

    • 13,376
    Privacy Policy
    %d